CBD News‎ > ‎

📰🌱 CBD Daily News March 9 2019

posted Mar 9, 2019, 9:07 AM by Scott Salisbury   [ updated Mar 9, 2019, 9:20 AM ]


Coke invested $90 million in Suja in 2015 at a reported $300 million valuation. The soda giant did not exercise an option to purchase the company last summer; Suja has been up for sale but has not yet found a buyer.

CBD is the most promising drug that has come out for neuropsychiatric diseases in the last 50 years,” said Dr. Esther Blessing, an assistant professor at New York University School of Medicine, who is coordinating a study of CBD as a treatment for post-traumatic stress disorder and alcohol use disorder. “The reason it is so promising is that it has a unique combination of safety and effectiveness across of very broad range of conditions.”